Chapter/Section Purchase

1 Study Coverage
1.1 Trastuzumab Biosimilar Product Introduction
1.2 Market by Type
1.2.1 Global Trastuzumab Biosimilar Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Adjuvant Breast Cancer
1.2.3 Metastatic Breast Cancer
1.2.4 Metastatic Gastric Cancer
1.2.5 Others
1.3 Market by Application
1.3.1 Global Trastuzumab Biosimilar Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Trastuzumab Biosimilar Sales Estimates and Forecasts 2017-2028
2.2 Global Trastuzumab Biosimilar Revenue Estimates and Forecasts 2017-2028
2.3 Global Trastuzumab Biosimilar Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Trastuzumab Biosimilar Sales by Region
2.4.1 Global Trastuzumab Biosimilar Sales by Region (2017-2022)
2.4.2 Global Sales Trastuzumab Biosimilar by Region (2023-2028)
2.5 Global Trastuzumab Biosimilar Revenue by Region
2.5.1 Global Trastuzumab Biosimilar Revenue by Region (2017-2022)
2.5.2 Global Trastuzumab Biosimilar Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Trastuzumab Biosimilar Sales by Manufacturers
3.1.1 Global Top Trastuzumab Biosimilar Manufacturers by Sales (2017-2022)
3.1.2 Global Trastuzumab Biosimilar Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Trastuzumab Biosimilar in 2021
3.2 Global Trastuzumab Biosimilar Revenue by Manufacturers
3.2.1 Global Trastuzumab Biosimilar Revenue by Manufacturers (2017-2022)
3.2.2 Global Trastuzumab Biosimilar Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Trastuzumab Biosimilar Revenue in 2021
3.3 Global Trastuzumab Biosimilar Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Trastuzumab Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Trastuzumab Biosimilar Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Trastuzumab Biosimilar Sales by Type
4.1.1 Global Trastuzumab Biosimilar Historical Sales by Type (2017-2022)
4.1.2 Global Trastuzumab Biosimilar Forecasted Sales by Type (2023-2028)
4.1.3 Global Trastuzumab Biosimilar Sales Market Share by Type (2017-2028)
4.2 Global Trastuzumab Biosimilar Revenue by Type
4.2.1 Global Trastuzumab Biosimilar Historical Revenue by Type (2017-2022)
4.2.2 Global Trastuzumab Biosimilar Forecasted Revenue by Type (2023-2028)
4.2.3 Global Trastuzumab Biosimilar Revenue Market Share by Type (2017-2028)
4.3 Global Trastuzumab Biosimilar Price by Type
4.3.1 Global Trastuzumab Biosimilar Price by Type (2017-2022)
4.3.2 Global Trastuzumab Biosimilar Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Trastuzumab Biosimilar Sales by Application
5.1.1 Global Trastuzumab Biosimilar Historical Sales by Application (2017-2022)
5.1.2 Global Trastuzumab Biosimilar Forecasted Sales by Application (2023-2028)
5.1.3 Global Trastuzumab Biosimilar Sales Market Share by Application (2017-2028)
5.2 Global Trastuzumab Biosimilar Revenue by Application
5.2.1 Global Trastuzumab Biosimilar Historical Revenue by Application (2017-2022)
5.2.2 Global Trastuzumab Biosimilar Forecasted Revenue by Application (2023-2028)
5.2.3 Global Trastuzumab Biosimilar Revenue Market Share by Application (2017-2028)
5.3 Global Trastuzumab Biosimilar Price by Application
5.3.1 Global Trastuzumab Biosimilar Price by Application (2017-2022)
5.3.2 Global Trastuzumab Biosimilar Price Forecast by Application (2023-2028)
6 North America
6.1 North America Trastuzumab Biosimilar Market Size by Type
6.1.1 North America Trastuzumab Biosimilar Sales by Type (2017-2028)
6.1.2 North America Trastuzumab Biosimilar Revenue by Type (2017-2028)
6.2 North America Trastuzumab Biosimilar Market Size by Application
6.2.1 North America Trastuzumab Biosimilar Sales by Application (2017-2028)
6.2.2 North America Trastuzumab Biosimilar Revenue by Application (2017-2028)
6.3 North America Trastuzumab Biosimilar Market Size by Country
6.3.1 North America Trastuzumab Biosimilar Sales by Country (2017-2028)
6.3.2 North America Trastuzumab Biosimilar Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Trastuzumab Biosimilar Market Size by Type
7.1.1 Europe Trastuzumab Biosimilar Sales by Type (2017-2028)
7.1.2 Europe Trastuzumab Biosimilar Revenue by Type (2017-2028)
7.2 Europe Trastuzumab Biosimilar Market Size by Application
7.2.1 Europe Trastuzumab Biosimilar Sales by Application (2017-2028)
7.2.2 Europe Trastuzumab Biosimilar Revenue by Application (2017-2028)
7.3 Europe Trastuzumab Biosimilar Market Size by Country
7.3.1 Europe Trastuzumab Biosimilar Sales by Country (2017-2028)
7.3.2 Europe Trastuzumab Biosimilar Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Trastuzumab Biosimilar Market Size by Type
8.1.1 Asia Pacific Trastuzumab Biosimilar Sales by Type (2017-2028)
8.1.2 Asia Pacific Trastuzumab Biosimilar Revenue by Type (2017-2028)
8.2 Asia Pacific Trastuzumab Biosimilar Market Size by Application
8.2.1 Asia Pacific Trastuzumab Biosimilar Sales by Application (2017-2028)
8.2.2 Asia Pacific Trastuzumab Biosimilar Revenue by Application (2017-2028)
8.3 Asia Pacific Trastuzumab Biosimilar Market Size by Region
8.3.1 Asia Pacific Trastuzumab Biosimilar Sales by Region (2017-2028)
8.3.2 Asia Pacific Trastuzumab Biosimilar Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Trastuzumab Biosimilar Market Size by Type
9.1.1 Latin America Trastuzumab Biosimilar Sales by Type (2017-2028)
9.1.2 Latin America Trastuzumab Biosimilar Revenue by Type (2017-2028)
9.2 Latin America Trastuzumab Biosimilar Market Size by Application
9.2.1 Latin America Trastuzumab Biosimilar Sales by Application (2017-2028)
9.2.2 Latin America Trastuzumab Biosimilar Revenue by Application (2017-2028)
9.3 Latin America Trastuzumab Biosimilar Market Size by Country
9.3.1 Latin America Trastuzumab Biosimilar Sales by Country (2017-2028)
9.3.2 Latin America Trastuzumab Biosimilar Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Trastuzumab Biosimilar Market Size by Type
10.1.1 Middle East and Africa Trastuzumab Biosimilar Sales by Type (2017-2028)
10.1.2 Middle East and Africa Trastuzumab Biosimilar Revenue by Type (2017-2028)
10.2 Middle East and Africa Trastuzumab Biosimilar Market Size by Application
10.2.1 Middle East and Africa Trastuzumab Biosimilar Sales by Application (2017-2028)
10.2.2 Middle East and Africa Trastuzumab Biosimilar Revenue by Application (2017-2028)
10.3 Middle East and Africa Trastuzumab Biosimilar Market Size by Country
10.3.1 Middle East and Africa Trastuzumab Biosimilar Sales by Country (2017-2028)
10.3.2 Middle East and Africa Trastuzumab Biosimilar Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Corporation Information
11.1.2 Amgen Inc. Overview
11.1.3 Amgen Inc. Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Amgen Inc. Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amgen Inc. Recent Developments
11.2 Pfizer Inc
11.2.1 Pfizer Inc Corporation Information
11.2.2 Pfizer Inc Overview
11.2.3 Pfizer Inc Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Inc Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Inc Recent Developments
11.3 Samsung Bioepis
11.3.1 Samsung Bioepis Corporation Information
11.3.2 Samsung Bioepis Overview
11.3.3 Samsung Bioepis Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Samsung Bioepis Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Samsung Bioepis Recent Developments
11.4 Merck & Co.
11.4.1 Merck & Co. Corporation Information
11.4.2 Merck & Co. Overview
11.4.3 Merck & Co. Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merck & Co. Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck & Co. Recent Developments
11.5 Biocon Limited
11.5.1 Biocon Limited Corporation Information
11.5.2 Biocon Limited Overview
11.5.3 Biocon Limited Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Biocon Limited Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biocon Limited Recent Developments
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Corporation Information
11.6.2 Teva Pharmaceutical Overview
11.6.3 Teva Pharmaceutical Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Teva Pharmaceutical Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Pharmaceutical Recent Developments
11.7 Genentech
11.7.1 Genentech Corporation Information
11.7.2 Genentech Overview
11.7.3 Genentech Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Genentech Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Genentech Recent Developments
11.8 Mundipharma
11.8.1 Mundipharma Corporation Information
11.8.2 Mundipharma Overview
11.8.3 Mundipharma Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Mundipharma Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Mundipharma Recent Developments
11.9 Celltrion
11.9.1 Celltrion Corporation Information
11.9.2 Celltrion Overview
11.9.3 Celltrion Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Celltrion Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Celltrion Recent Developments
11.10 Henlius
11.10.1 Henlius Corporation Information
11.10.2 Henlius Overview
11.10.3 Henlius Trastuzumab Biosimilar Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Henlius Trastuzumab Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Henlius Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Trastuzumab Biosimilar Industry Chain Analysis
12.2 Trastuzumab Biosimilar Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Trastuzumab Biosimilar Production Mode & Process
12.4 Trastuzumab Biosimilar Sales and Marketing
12.4.1 Trastuzumab Biosimilar Sales Channels
12.4.2 Trastuzumab Biosimilar Distributors
12.5 Trastuzumab Biosimilar Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Trastuzumab Biosimilar Industry Trends
13.2 Trastuzumab Biosimilar Market Drivers
13.3 Trastuzumab Biosimilar Market Challenges
13.4 Trastuzumab Biosimilar Market Restraints
14 Key Findings in The Global Trastuzumab Biosimilar Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer